Announcements Partners

ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer

Oric Logo

Carrick Therapeutics Announces $35 Million Investment from Pfizer

Carrick Logo

Anokion Announces $35 Million Equity Investment from Pfizer

Anokion Logo

Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer

Zentalis Logo